Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cardiovascular drugs and the genetic response.

Methodist DeBakey cardiovascular journal - 1 Jan 2000

Dandona Sonny

Abstract excerpt

The emergence of personalized medicine mandates a complete understating of DNA sequence variation that modulates drug response. Initial forays have been made in the cardiac arena, yet much remains to be elucidated in the pharmacogenetics of cardiac drugs. Most progress has been made in describing DNA sequence variation related to the anticoagulant warfarin and the antiplatelet drug clopidogrel. This includes a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Precision Medicine
Share to Biotransformation
Share to Cardiovascular Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiovascular Diseases

Share to Drug Interactions

Share to Pharmacogenetics

Share to Risk Assessment

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 24932357
DOI: 10.14797/mdcj-10-1-13
PMCID: PMC4051328

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cardiovascular drugs and the genetic response.PMID 24932357Read ↗

Cardiovascular pharmacogenomics.Semantic proximity Read ↗

Cardiovascular pharmacogenomics and individualized drug therapy.Semantic proximity Read ↗

Cardiovascular pharmacogenomics: current status and future directions.Semantic proximity Read ↗

Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.Semantic proximity Read ↗

Pharmacogenomics in cardiac therapy: Personalizing treatment for heart healthSemantic proximity Read ↗

Pharmacogenetics and cardiovascular disease--implications for personalized medicine.Semantic proximity Read ↗

Genetic determinants of response to cardiovascular drugs.Semantic proximity Read ↗

Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).Semantic proximity Read ↗

Use of Pharmacogenetic Information in the Treatment of Cardiovascular Disease.Semantic proximity Read ↗

Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine.Semantic proximity Read ↗

Personalized medicine in cardiology: the time for genotype-guided therapy is now.Semantic proximity Read ↗

[Pharmacogenomics for cardiovascular drugs].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.